A newly approved National Cancer Institute-funded clinical trial aims to improve survival for head and neck cancer patients ...

Oral stents have emerged as a valuable adjunct in the radiotherapy of head and neck cancer, allowing clinicians to displace and immobilise non-target tissues, thereby reducing radiation exposure to ...

Two new exploratory studies of radioenhancers used in combination with radiation therapy in the treatment of head and neck cancers showed that these agents can boost the effectiveness of radiotherapy ...

A small prospective study from Taiwan showed that olfactory function begins to deteriorate at a radiation therapy dose of 22 Gy in patients with head and neck cancer. Only 17% of patients developed ...

For the last 20 years, the standard-of-care adjuvant treatment for resected pathologically defined high-risk resected locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) has been ...

Radiation treatment planning considerations to reduce the risk of developing ORN. Indications and timing of preradiation dental evaluation and frequency of long-term dental follow-up and management ...